U.S., Europe and Australia Team Up to Inspect Chinese Factories
More than a hundred people have died as a result of receiving heparin contaminated in Chinese factories. Now, the U.S., Europe and Australia have agreed to coordinate the inspections of drug-making factories in China and India, the Associated Press reports.
The pilot program was announced on July 9. It is hoped that the effort will allow regulators to inspect more factories.
Inspections are urgently needed. There have been at least 149 deaths in the U.S. of people who had allergic reactions after receiving contaminated doses of the blood thinner heparin. So far, ten countries have reported the presence of contaminated heparin. They include: Australia, Canada, China, France, Germany, Italy, Japan, The Netherlands, New Zealand, and the United States.
Continue reading "U.S., Europe and Australia Team Up to Inspect Chinese Factories" »